当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析

贝达药业

(300558)

  

流通市值:236.46亿  总市值:237.20亿
流通股本:4.17亿   总股本:4.18亿

贝达药业(300558)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润4.05亿元,每股收益0.99元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益572611.13万元,未分配利润263830.41万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产935797.21万元,负债363186.08万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入2,344,643,009.241,500,765,619.93735,775,468.82,456,196,486.62
营业总成本1,978,236,019.161,261,367,094.02641,561,760.142,213,916,621.77
营业利润438,271,814.06253,891,097.59108,359,629.25270,069,503.79
利润总额431,823,507.59250,082,716.09107,227,308.89322,074,564.19
净利润405,153,844.02216,123,850.7593,790,802.53333,615,704.19
其他综合收益-32,146,129.6114,552,762.64147,493,168.2260,755,488.95
综合收益总额373,007,714.41230,676,613.39241,283,970.75394,371,193.14
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,526,566,689.451,184,580,501.761,291,522,377.581,525,880,626.51
非流动资产合计7,831,405,379.987,957,303,939.688,034,937,681.37,621,027,769.02
资产总计9,357,972,069.439,141,884,441.449,326,460,058.889,146,908,395.53
流动负债合计1,776,897,468.141,691,250,986.521,420,328,462.731,803,156,867.03
非流动负债合计1,854,963,323.221,886,496,244.892,293,291,663.581,992,277,869.7
负债合计3,631,860,791.363,577,747,231.413,713,620,126.313,795,434,736.73
归属于母公司股东权益合计5,636,950,298.895,471,675,324.945,522,175,127.325,251,077,081.9
股东权益合计5,726,111,278.075,564,137,210.035,612,839,932.575,351,473,658.8
负债和股东权益合计9,357,972,069.439,141,884,441.449,326,460,058.889,146,908,395.53
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计2,548,182,394.11,663,805,651.24868,051,394.752,971,883,647.83
经营活动现金流出小计1,716,841,655.311,142,113,321.65620,815,791.632,057,655,670.33
经营活动产生的现金流量净额831,340,738.79521,692,329.59247,235,603.12914,227,977.5
投资活动现金流入小计2,050,815.97140,367-22,213,036.88
投资活动现金流出小计783,733,321.62640,864,277.77491,145,434.911,527,665,941.92
投资活动产生的现金流量净额-781,682,505.65-640,723,910.77-491,145,434.91-1,505,452,905.04
筹资活动现金流入小计483,600,000408,600,000308,600,0001,950,788,152.19
筹资活动现金流出小计683,894,076.8575,676,906.49261,025,439.531,342,594,801.63
筹资活动产生的现金流量净额-200,294,076.8-167,076,906.4947,574,560.47608,193,350.56
汇率变动对现金及现金等价物的影响-6,019,687.56-983,640.38-1,641,143.493,743,631.8
现金及现金等价物净增加额-156,655,531.22-287,092,128.05-197,976,414.8120,712,054.82
期末现金及现金等价物余额595,341,383.28464,904,786.45554,020,499.69751,996,914.5
最新报告期:2024-12-13
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
海通证券余文心1.212.143.142024-12-13
海通证券余文心1.212.143.232024-11-27
西部证券李梦园1.231.862.102024-11-26
TOP↑